SGEN vs TBPH
SGEN (SGEN) versus Theravance Biopharma Inc (TBPH) — a side-by-side from cached financials, not a winner call.
SGEN (SGEN) common stock.
Theravance Biopharma Inc (TBPH) is a biotechnology company listed on NASDAQ.
SGEN does not have a complete income-statement cache yet.
Latest reported TBPH revenue for 2026-06-30 was $38.4M. Net income was -$10.8M. TBPH currently screens at market cap $861.5M and trailing P/E 7.5.
TBPH currently screens at market cap $861.5M and trailing P/E 7.5.
Not investment advice. Open the SGEN and TBPH stock pages for the full models.
Not investment advice.